The recent increase in the global burden of early-onset CRC underscores the need for targeted early detection and intervention programmes in younger populations.30, 31, 32 In addition, the association between elevated CRP and survival in older patients could be confounded by several factors including age-related comorbidities.33 This evidence concerns the gene CRP and colorectal carcinoma.